Differences in clinical features between axial psoriatic arthritis and axial spondyloarthritis: a systematic review and meta-analysis of observational studies

• by Zhihao Qiu, Zijie Chen, Zhe Yang, Ruibo Xia, Weikai Chen, Yuwei Zhu, Weijie Wang, Zhengfu Li, Kepeng Yang

• June 22, 2026

​​​​​​​PsA Treatment Options Expand

Phase 3 POETYK trial results support FDA approval of deucravacitinib for adults with active PsA.

• by Kathryn Wighton

• March 9, 2026

• 3 min

Inflammatory marker profiles vary by BMI across Crohn’s disease, ulcerative colitis, psoriasis, and psoriatic arthritis

• by Stephen A. Shields, Ann Von Holle, Ruthvik Padival, Joseph F. Merola, Rachael Zuckerman, Jeff T. Mohl, Elizabeth L. Ciemins

• July 17, 2026

Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry

• by Jennifer Beecker, Lorne Albrecht, Ignacio Dei-Cas, Melinda Gooderham, Charles Lynde, Kim A. Papp, Paul Keown, Antonio Vieira, Mahmoud S. Farag, Marie Maguin, Tanya Zappitelli, Philip S. Helliwell

• July 21, 2026